Meet Our Teams

JULIE SAWYER-MONTGOMERY

PRESIDENT, BECKMAN COULTER DIAGNOSTICS
In her role as President, Beckman Coulter Diagnostics, Julie Sawyer Montgomery leads our vision to advance healthcare for every person.

Prior to assuming this role in January 2020, Julie served as Senior Vice President, Products, Global Marketing and Developed Markets.

Julie joined Beckman Coulter in 2017 from Hospira Infusion Systems, a part of Pfizer, where she was President and held other progressive leadership roles including U.S. region president; Vice President, Global Marketing; and Vice President, International Sales. Prior to Hospira, Julie led marketing strategy for Boston Scientific’s cardiovascular division and supported Fortune 500 healthcare clients as a project leader at The Boston Consulting Group.

At Beckman Coulter, Julie has built on the company’s longstanding focus to deliver market-leading products and services by accelerating new product innovation and strengthening commercial execution.

Julie earned her Bachelor of Arts from Columbia University, a Master of Music from the Eastman School of Music and a Master of Business Administration from Harvard Business School.

SARAH MOORE 

SENIOR VICE PRESIDENT, DEVELOPED MARKETS
Sarah joined us in 2018 and since then has done an outstanding job of accelerating our commercial improvement agenda in North and Latin America and Europe, including returning North America to core growth for the first time in five years. Sarah has brought great energy, focus and creativity to our North America commercial strategy, and is leading our efforts to enhance collaboration between sales and service to drive improved customer experience and retention. She has also been instrumental in driving a stronger articulation of the Beckman Coulter value proposition and is passionate about our associates and our customers.

Sarah brings years of commercial experience from Siemens Healthineers where she held various positions of increasing responsibilities, including both Commercial and Business Unit leadership roles, prior to joining Beckman Coulter Diagnostics. Sarah has a B.S. in Biochemistry from Loyola Marymount University.

MARIANNE OVESEN

SENIOR VICE PRESIDENT, GLOBAL OPERATIONS
Marianne joined Beckman Coulter as senior vice president of global operations in 2019. Previously, Marianne served as Vice President of Operations with Radiometer. She joined Radioemeter in 2008 as QA Manager and progressed to Director of QA before taking on the Operations role.

Marianne holds a Masters degree in Food Science from the University of Copenhagen.

VIBEKE HOLST-ANDERSEN 

SENIOR VICE PRESIDENT, LEGAL & GENERAL COUNSEL
Vibeke joined Beckman in June 2019 after more than six years as Radiometer VP Legal and General Counsel. She has also been the Diagnostics Platform Regional Counsel, Europe for three years and the Danaher Russia Counsel four years. Vibeke started her career with 8 years in private practice in Copenhagen, mainly focusing on litigation. Later she became in-house counsel and has experience as a GC in multi-national companies, among others within the diagnostic industry.

Vibeke is licensed to practice law in Denmark.

NOREEN GALVIN

SENIOR VICE PRESIDENT, QUALITY, REGULATORY CLINICAL AFFAIRS
Noreen Galvin is SVP, Quality, Regulatory and Clinical Affairs for Beckman Coulter Diagnostics. She joined Beckman Coulter in 1995 and has held roles in various functions including R&D, European commercial operations, service, strategic marketing, product management and technical support. She earned a bachelor’s degree in Microbiology and Biochemistry and Ph.D. in Microbiology, both from University College Dublin, Ireland.

Timea Zsiray

Vice President, Global Marketing

Timea Zsiray is Vice President, Global Marketing. She joined Beckman Coulter in 2018 as Director, Strategy and Partnership, later serving as Senior Director, Global Product Marketing where she spearheaded new product commercialization and launch excellence.

Prior to joining Beckman Coulter Diagnostics, Timea led commercial marketing strategy and execution at ICU Medical, previously Hospira Infusion Systems, a Pfizer company. She also held various marketing positions of increasing responsibilities at GE Healthcare.

Timea earned her Bachelor of Arts degree in Finance from Budapest Business School and an MBA from Marquette University.

MICKEY BLANKS

SENIOR VICE PRESIDENT, HUMAN RESOURCES & COMMUNICATIONS
Mickey joined Beckman Coulter in 2017 from the Mosaic Company, where he led as Vice President, Human Resources for Commercial and Global Supply Chain. While at Mosaic, Mickey developed the global commercial sales incentive program and led talent and change management for the company’s five-year customer delivery strategy. Prior to Mosaic, he held HR positions of increasing responsibilities in various organizations, including IMI Cornelius, American Standard Brands and Unilever.

Mickey’s upbringing as the son of two U.S. military veterans influenced his “servant leadership” approach at work and in the community. He believes in the power of mentoring young professionals and volunteers with his wife and children for organizations like Habitat for Humanity and local nursing homes.

Mickey earned his Bachelor of Arts in Industrial and Organizational Psychology from Kean University, a Master of Arts in Industrial and Labor Relations from the University of Illinois at Urbana-Champaign; and a Master of Business Administration from the Carlson School of Management at the University of Minnesota.

KATHLEEN ORLAND

SENIOR VICE PRESIDENT & GENERAL MANAGER, CLINICAL CHEMISTRY AND IMMUNOASSAY
Kathleen currently serves as Senior Vice President and General Manager for the Clinical Chemistry Immunoassay (CCIA) Business Unit, leading product strategy and new product development programs across eight global sites. Kathleen began her career journey at Beckman Coulter in 2005 as a Senior Product Manager for Immunoassay. Since then, Kathleen has contributed to our success in a variety of roles, including Director, Immunoassay Product Management; VP, Clinical Chemistry Immunoassay Product Management; VP, Danaher Business System and Global Marketing. Kathleen was instrumental in helping us define our customer value proposition and build launch excellence capability. Kathleen’s extensive industry knowledge and DBS expertise combined with her passion for innovation and solving customer problems drives the CCIA team meet their strategic goals.

Kathleen has a bachelor’s degree in microbiology from University of Illinois at Urbana-Champaign and earned her Medical Technologist MT (ASCP) from NorthShore University HealthSystem in Evanston, Illinois.

PETER SOLTANI

SENIOR VICE PRESIDENT & GENERAL MANAGER, HEMATOLOGY, URINALYSIS & WORKFLOW INFORMATION TECHNOLOGY SOLUTIONS
Dr. Peter Soltani, SVP and general manager of our Hematology, Urinalysis & WITS business unit, joined Beckman Coulter Diagnostics in 2016. Since then he has led the accelerated turnaround of our hematology business by bringing significant innovation to market, including the new DxH 900 and DxH 520 instruments and the revolutionary Early Sepsis Indicator.

Peter has been a key contributor to improving our standard work for New Product Development and product launch. Peter is responsible for the commercial success of our new automation offering, the DxA 5000, and charting an ambitious path toward Informatics leadership in the diagnostics industry.

Peter has a Bachelor’s degree in Chemistry and a Ph.D. in Materials Engineering from the University of Maryland.

TIFFANY MURPHY

VICE PRESIDENT, DANAHER BUSINESS SYSTEM & SPECIAL PROJECTS

Tiffany Murphy is responsible for driving global Danaher Business System (DBS) capability and continuous improvement by linking DBS to Core Value Drivers.  In her role, Tiffany builds sustainable competitive advantage by driving Beckman Coulter’s DBS culture and facilitating policy deployment to reach global breakthrough performance.

Tiffany joined Beckman Coulter in 2000 and brings more than 20 years of diagnostic and life science commercial experience. Most recently, she served as Vice President of Sales, North America, where she led a multi-year sales optimization and effectiveness plan that resulted in solid financial growth, high customer retention and associate engagement. 

Tiffany earned a Bachelor of Arts in Biology from Baylor University and a Master of Business Administration from Texas A&M University.

ANAGH A. VORA, M.D.

CHIEF MEDICAL OFFICER AND SENIOR VICE PRESIDENT, MEDICAL & SCIENTIFIC AFFAIRS

Anagh A. Vora, M.D. is responsible for increasing clinical insight, developing markets for new products and improving medical education.  

Dr. Vora joined Beckman Coulter in 2020. Before joining Beckman Coulter, Dr. Vora served as Head of Medical Affairs for the drug development arm of LabCorp. During his more than 15-year career in the diagnostic and therapeutic space, Dr. Vora gained extensive medical affairs experience focused on the commercialization of novel diagnostics and new treatments to help improve patient health.

Dr. Vora holds a Bachelor of Science in Biology, a Master of Science in Immunology from the University of South Carolina, and an M.D. from the Royal College of Surgeons. Dr. Vora was trained as a pathologist at Washington University at Saint Louis and University of California Los Angeles.

BARRY LYON

PRESIDENT, MICROBIOLOGY
Barry Lyon is President of Beckman Coulter Microbiology, a leader in the accurate detection of emerging antimicrobial resistance.

Barry joined Beckman Coulter in February 2021 from Danaher’s Water Quality Platform, where he most recently served as President of Sea-Bird Scientific. Prior to that, Barry led as Vice President, Global Marketing at Hach, a Danaher operating company. Barry has collaborated extensively with the scientific community in these roles; building on Sea-Bird’s rich history of developing novel solutions for global observation programs in marine research science, and leading Hach’s technical training center and directing regulatory affairs with the U.S. Environmental Protection Agency (EPA) and International Organization for Standardization (ISO). 

He holds a Bachelor of Science in Business from the University of Oregon and a Master of Business Administration from Loyola University Maryland.

ROSS BELL

SENIOR VICE PRESIDENT & CHIEF FINANCIAL OFFICER

Ross Bell is Senior Vice President & Chief Financial Officer overseeing the company’s finance and IT operations.

Ross joined Beckman Coulter in 2017 and most recently served as Vice President, Finance for Beckman Coulter’s Developed Markets and business units. In this role, he strengthened the compliance and accounting function, helped drive operating margin expansion initiatives and supported key product launches while stewarding overall R&D investments. Ross started his career at PricewaterhouseCoopers LLP and then held progressive finance leadership roles at Eastman Kodak Company, Lennox International, and Corning Inc.   

Ross earned his Bachelor of Business Administration in Accounting and his Master of Business Administration from Saint Bonaventure University. 

SAID HADDAD

SENIOR VICE PRESIDENT, HIGH GROWTH MARKETS

Said Haddad is responsible for leading direct and distributed teams of 2,500 sales and support professionals located across Beckman Coulter’s high growth market regions.

Said joined Beckman Coulter in 2021 from Johnson & Johnson’s medical device sector where he demonstrated a strong 20-year track record of success in a range of commercial and upstream leadership roles. In his most recent role, Said led the Ethicon business in Europe, Middle East and Africa (EMEA), achieving above-market growth and business turnaround in multiple countries.

Said earned his Bachelor of Business Administration and Bachelor of Science in Biology from American University of Beirut and a Master of Business Administration from American University, Washington D.C.

Tom Neufelder

Senior Vice President, Software, Systems & Automation

Tom Neufelder leads software development, systems engineering and automation in the diagnostic workflow at Beckman Coulter Diagnostics.

Prior to joining Beckman Coulter in 2021, Tom served as Chief Technology Officer for MaxQ AI which develops artificial intelligence and machine learning applications for detection of intracranial hemorrhage. Tom has held numerous senior executive positions at various companies including Philips Healthcare and GE Healthcare. He brings more than 35 years of experience in engineering and product development to his role at Beckman Coulter.

Tom holds a Master of Science degree in Electrical Engineering from Johns Hopkins University and a Bachelor of Science degree in Electrical Engineering from Rose-Hulman Institute of Technology.